SSRI Versus Bupropion in High-Risk Major Depressive Disorder
Phase of Trial: Phase IV
Latest Information Update: 17 Feb 2017
Price : $35 *
At a glance
- Drugs Bupropion (Primary) ; Paroxetine (Primary)
- Indications Major depressive disorder; Suicidal ideation
- Focus Therapeutic Use
- 05 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Sep 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 31 Dec 2012 New trial record